查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1705581

2025年全球病人自控注射器市場報告

Patient Controlled Injectors Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年患者控制注射器市場規模將快速成長。到 2029 年，這一數字將成長至 82.5 億美元，複合年成長率為 12.8%。預測期內的成長是由於人口老化加劇、慢性呼吸系統疾病發生率上升、慢性病盛行率上升、癌症發生率上升以及自體免疫疾病盛行率上升。預測期內的關鍵趨勢包括技術進步、人工智慧融合、遠端醫療、遠端監控、攜帶式和穿戴式設備的進步以及對微創手術的重視。

預計未來幾年慢性病盛行率的上升將推動患者控制注射器市場的成長。人口老化、肥胖症流行、經濟狀況、環境因素和其他因素導致持續時間超過三個月且往往會隨著時間的推移而惡化的慢性病增加。患者控制注射器使患者能夠根據治療計劃準確、方便地自行給藥。例如，美國國家生物技術資訊中心（NCBI）在2023年1月預測，到2050年，患有一種或多種慢性病的50歲及以上人群的數量將增加99.5%，從2020年的7152萬人增加到1.4266億人。因此，慢性病盛行率的不斷上升有望推動患者控制注射器市場的發展。

該市場的主要企業正在創新和開發即用型注射器等先進產品，以更好地滿足客戶的需求。即用型注射器已預先填充並消毒了精確量的藥物，無需手動準備，並降低了污染和管理錯誤的風險。例如，2022 年 10 月，Ypsomed AG 推出了一款新型自動注射器平台，專門用於 1.5 至 5.5 毫升之間的液體藥物。該設備具有符合人體工學、易於使用的設計，確保患者在注射過程中的舒適度，並具有先進的安全功能以防止針刺傷。它還具有多種黏度，可用於各種治療應用。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、感染疾病、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球病人控制注射器市場 PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球病人控制注射器市場：成長率分析
  • 全球病人控制注射器市場表現：規模與成長，2019-2024
  • 全球病患自控注射器市場預測：規模與成長，2024-2029 年，2034 年
  • 全球病人自控注射器總目標市場（TAM）

第6章市場區隔

  • 全球病患自控注射器市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 電子穿戴式注射器
  • 穿戴式機械注射器
  • 點滴幫浦
  • 全球病患自控注射器市場：依應用、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 癌症治療
  • 自體免疫治療
  • 血液疾病的治療
  • 其他應用
  • 全球病患自控注射器市場：依通路、實際資料及預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院藥房
  • 零售藥局
  • 通訊藥房
  • 全球病患控制注射器市場、電子穿戴式注射器細分市場、按類型、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 預填充電子穿戴式注射器
  • 可程式設計電子穿戴式注射器
  • 智慧電子穿戴式注射器
  • 充電式電子穿戴式注射器
  • 支援藍牙的穿戴式電子注射器
  • 免洗電子穿戴式注射器
  • 全球病患控制注射器市場機械穿戴式注射器細分（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 彈簧式機械穿戴式注射器
  • 穿戴式活塞機械注射器
  • 自動注射器（機械）
  • 手動機械穿戴式注射器
  • 免洗式穿戴式機械注射器
  • 全球病人控制注射器市場輸液幫浦細分（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 一次性輸液泵
  • 可程式設計輸液泵
  • 胰島素輸注泵
  • 注射輸液幫浦
  • 攜帶式輸液泵
  • 大容量輸液泵
  • 植入式輸液泵

第7章 區域和國家分析

  • 全球病患自控注射器市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球病患自控注射器市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 病患控制注射器市場：競爭格局
  • 病患控制注射器市場：公司簡介
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • West Pharmaceutical Services Overview, Products and Services, Strategy and Financial Analysis
    • SCHOTT AG Overview, Products and Services, Strategy and Financial Analysis
    • Gerresheimer AG Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Phillips-Medisize
  • Vetter Pharma-Fertigung GmbH & Co. KG
  • Stevanato Group
  • Ypsomed AG
  • Nemera
  • B. Braun Melsungen AG
  • Elcam Medical
  • Owen Mumford
  • Bespak
  • Unilife Corporation
  • Crossject
  • SHL Group
  • AptarGroup Inc.
  • Credence MedSystems
  • Weibel CDS AG

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年病患自控注射器市場：提供新機會的國家
  • 2029年病患自控注射器市場：細分市場帶來新機會
  • 2029年病患控制注射器市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r30899

Patient-controlled injectors are medical devices designed to empower patients to self-administer medication with precise control over dosage and timing. They are user-friendly, facilitating independent management of treatment, typically in home settings.

The primary types of patient-controlled injectors include electronic wearable injectors, mechanical wearable injectors, and infusion pumps. Electronic versions enable automated and precise medication delivery, often equipped with connectivity features for tracking and monitoring usage. This enhances convenience and provides data-driven insights for patients. These devices find applications in treatments such as cancer, autoimmune disorders, and blood disorders, distributed through hospital pharmacies, retail pharmacies, and mail-order channels.

The patient-controlled injectors market research report is one of a series of new reports from The Business Research Company that provides patient-controlled injectors market statistics, including patient-controlled injectors industry global market size, regional shares, competitors with a patient-controlled injectors market share, detailed patient-controlled injectors market segments, market trends, and opportunities, and any further data you may need to thrive in the patient-controlled injectors industry. This patient-controlled injectors research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The patient controlled injectors market size has grown rapidly in recent years. It will grow from $4.51 billion in 2024 to $5.1 billion in 2025 at a compound annual growth rate (CAGR) of 13.1%. The growth in the historic period can be attributed to growth in home healthcare, expansion of healthcare infrastructure, increasing cases of diabetes, increased prevalence of infectious diseases, and increasing focus on personalized medicine.

The patient controlled injectors market size is expected to see rapid growth in the next few years. It will grow to $8.25 billion in 2029 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to a rising aging population, rising incidence of chronic respiratory diseases, increasing prevalence of chronic diseases, increasing cancer cases, and increasing autoimmune disorders prevalence. Major trends in the forecast period include technological advancements, integration of artificial intelligence, telemedicine, remote monitoring, advancements in portable and wearable devices, and focus on minimally invasive procedures.

The rising prevalence of chronic diseases is poised to drive the growth of the patient-controlled injectors market in the coming years. Chronic illnesses, lasting three months or more and often worsening over time, are increasing due to factors such as an aging population, the obesity epidemic, socioeconomic conditions, and environmental factors. Patient-controlled injectors enable individuals to self-administer medications accurately, conveniently, and according to their treatment schedules. For example, the National Center for Biotechnology Information (NCBI) projected in January 2023 that the number of individuals aged 50 and older with one or more chronic conditions will rise by 99.5% by 2050, from 71.52 million in 2020 to 142.66 million. Therefore, the growing prevalence of chronic diseases is expected to propel the patient-controlled injectors market forward.

Leading companies in this market are innovating by developing advanced products such as ready-to-use syringes to better meet customer needs. Ready-to-use syringes come prefilled and sterilized with a precise dose of medication, eliminating the need for manual preparation and reducing risks of contamination and dosing errors. For instance, in October 2022, Ypsomed AG introduced a new autoinjector platform tailored for liquid pharmaceuticals ranging from 1.5 to 5.5 ml. This device features ergonomic design for ease of use, ensuring patient comfort during injections, along with advanced safety mechanisms to prevent accidental needle sticks. It provides visual and audible feedback to confirm successful medication delivery and is versatile for various therapeutic applications due to its compatibility with different viscosities.

In April 2023, LTS Lohmann Therapie-Systeme AG expanded its drug delivery portfolio by acquiring the sorrel wearable injection device business from Eitan Medical. This acquisition enhances LTS's capabilities in advanced wearable injection technologies, further solidifying its presence in the patient-controlled injectors market. Eitan Medical Ltd. is an Israel-based company that develops innovative drug delivery devices, including patient-controlled injectors.

Major companies operating in the patient controlled injectors market are Medtronic plc, Becton Dickinson and Company, West Pharmaceutical Services, SCHOTT AG, Gerresheimer AG, Phillips-Medisize, Vetter Pharma-Fertigung GmbH & Co. KG, Stevanato Group, Ypsomed AG, Nemera, B. Braun Melsungen AG, Elcam Medical, Owen Mumford, Bespak, Unilife Corporation, Crossject, SHL Group, AptarGroup Inc., Credence MedSystems, Weibel CDS AG, Sorrel Medical

North America was the largest region in the patient controlled injectors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the patient controlled injectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the patient controlled injectors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The patient-controlled injectors market consists of sales of prefilled syringes, auto-injectors, on-body injectors, and needle-free injectors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Patient Controlled Injectors Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on patient controlled injectors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for patient controlled injectors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The patient controlled injectors market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Electronic Wearable Injector; Mechanical Wearable Injector; Infusion Pumps
  • 2) By Application: Cancer Treatment; Auto-Immune Treatment; Blood Disorder Treatment; Other Application
  • 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Mail Order Pharmacies
  • Subsegments:
  • 1) By Electronic Wearable Injector: Pre-Filled Electronic Wearable Injectors; Programmable Electronic Wearable Injectors; Smart Electronic Wearable Injectors; Rechargeable Electronic Wearable Injectors; Bluetooth-Enabled Electronic Wearable Injectors; Disposable Electronic Wearable Injectors
  • 2) By Mechanical Wearable Injector: Spring-Loaded Mechanical Wearable Injectors; Piston-Based Mechanical Wearable Injectors; Auto-Injectors (Mechanical); Manual Mechanical Wearable Injectors; Disposable Mechanical Wearable Injectors
  • 3) By Infusion Pumps: Disposable Infusion Pumps; Programmable Infusion Pumps; Insulin Infusion Pumps; Syringe Infusion Pumps; Ambulatory Infusion Pumps; Large Volume Infusion Pumps; Implantable Infusion Pumps
  • Companies Mentioned: Medtronic plc; Becton Dickinson and Company; West Pharmaceutical Services; SCHOTT AG; Gerresheimer AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Patient Controlled Injectors Market Characteristics

3. Patient Controlled Injectors Market Trends And Strategies

4. Patient Controlled Injectors Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Patient Controlled Injectors Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Patient Controlled Injectors PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Patient Controlled Injectors Market Growth Rate Analysis
  • 5.4. Global Patient Controlled Injectors Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Patient Controlled Injectors Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Patient Controlled Injectors Total Addressable Market (TAM)

6. Patient Controlled Injectors Market Segmentation

  • 6.1. Global Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Electronic Wearable Injector
  • Mechanical Wearable Injector
  • Infusion Pumps
  • 6.2. Global Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer Treatment
  • Auto-Immune Treatment
  • Blood Disorder Treatment
  • Other Application
  • 6.3. Global Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Mail Order Pharmacies
  • 6.4. Global Patient Controlled Injectors Market, Sub-Segmentation Of Electronic Wearable Injector, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pre-Filled Electronic Wearable Injectors
  • Programmable Electronic Wearable Injectors
  • Smart Electronic Wearable Injectors
  • Rechargeable Electronic Wearable Injectors
  • Bluetooth-Enabled Electronic Wearable Injectors
  • Disposable Electronic Wearable Injectors
  • 6.5. Global Patient Controlled Injectors Market, Sub-Segmentation Of Mechanical Wearable Injector, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Spring-Loaded Mechanical Wearable Injectors
  • Piston-Based Mechanical Wearable Injectors
  • Auto-Injectors (Mechanical)
  • Manual Mechanical Wearable Injectors
  • Disposable Mechanical Wearable Injectors
  • 6.6. Global Patient Controlled Injectors Market, Sub-Segmentation Of Infusion Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Disposable Infusion Pumps
  • Programmable Infusion Pumps
  • Insulin Infusion Pumps
  • Syringe Infusion Pumps
  • Ambulatory Infusion Pumps
  • Large Volume Infusion Pumps
  • Implantable Infusion Pumps

7. Patient Controlled Injectors Market Regional And Country Analysis

  • 7.1. Global Patient Controlled Injectors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Patient Controlled Injectors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Patient Controlled Injectors Market

  • 8.1. Asia-Pacific Patient Controlled Injectors Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Patient Controlled Injectors Market

  • 9.1. China Patient Controlled Injectors Market Overview
  • 9.2. China Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Patient Controlled Injectors Market

  • 10.1. India Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Patient Controlled Injectors Market

  • 11.1. Japan Patient Controlled Injectors Market Overview
  • 11.2. Japan Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Patient Controlled Injectors Market

  • 12.1. Australia Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Patient Controlled Injectors Market

  • 13.1. Indonesia Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Patient Controlled Injectors Market

  • 14.1. South Korea Patient Controlled Injectors Market Overview
  • 14.2. South Korea Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Patient Controlled Injectors Market

  • 15.1. Western Europe Patient Controlled Injectors Market Overview
  • 15.2. Western Europe Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Patient Controlled Injectors Market

  • 16.1. UK Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Patient Controlled Injectors Market

  • 17.1. Germany Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Patient Controlled Injectors Market

  • 18.1. France Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Patient Controlled Injectors Market

  • 19.1. Italy Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Patient Controlled Injectors Market

  • 20.1. Spain Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Patient Controlled Injectors Market

  • 21.1. Eastern Europe Patient Controlled Injectors Market Overview
  • 21.2. Eastern Europe Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Patient Controlled Injectors Market

  • 22.1. Russia Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Patient Controlled Injectors Market

  • 23.1. North America Patient Controlled Injectors Market Overview
  • 23.2. North America Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Patient Controlled Injectors Market

  • 24.1. USA Patient Controlled Injectors Market Overview
  • 24.2. USA Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Patient Controlled Injectors Market

  • 25.1. Canada Patient Controlled Injectors Market Overview
  • 25.2. Canada Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Patient Controlled Injectors Market

  • 26.1. South America Patient Controlled Injectors Market Overview
  • 26.2. South America Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Patient Controlled Injectors Market

  • 27.1. Brazil Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Patient Controlled Injectors Market

  • 28.1. Middle East Patient Controlled Injectors Market Overview
  • 28.2. Middle East Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Patient Controlled Injectors Market

  • 29.1. Africa Patient Controlled Injectors Market Overview
  • 29.2. Africa Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Patient Controlled Injectors Market Competitive Landscape And Company Profiles

  • 30.1. Patient Controlled Injectors Market Competitive Landscape
  • 30.2. Patient Controlled Injectors Market Company Profiles
    • 30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. West Pharmaceutical Services Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. SCHOTT AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Gerresheimer AG Overview, Products and Services, Strategy and Financial Analysis

31. Patient Controlled Injectors Market Other Major And Innovative Companies

  • 31.1. Phillips-Medisize
  • 31.2. Vetter Pharma-Fertigung GmbH & Co. KG
  • 31.3. Stevanato Group
  • 31.4. Ypsomed AG
  • 31.5. Nemera
  • 31.6. B. Braun Melsungen AG
  • 31.7. Elcam Medical
  • 31.8. Owen Mumford
  • 31.9. Bespak
  • 31.10. Unilife Corporation
  • 31.11. Crossject
  • 31.12. SHL Group
  • 31.13. AptarGroup Inc.
  • 31.14. Credence MedSystems
  • 31.15. Weibel CDS AG

32. Global Patient Controlled Injectors Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Patient Controlled Injectors Market

34. Recent Developments In The Patient Controlled Injectors Market

35. Patient Controlled Injectors Market High Potential Countries, Segments and Strategies

  • 35.1 Patient Controlled Injectors Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Patient Controlled Injectors Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Patient Controlled Injectors Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer